Cargando…

Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis

The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited know...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaff, Abigail L., Bubb, Vivien J., Quinn, John P., Koks, Sulev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961898/
https://www.ncbi.nlm.nih.gov/pubmed/35346298
http://dx.doi.org/10.1186/s13041-022-00914-x
_version_ 1784677686675767296
author Pfaff, Abigail L.
Bubb, Vivien J.
Quinn, John P.
Koks, Sulev
author_facet Pfaff, Abigail L.
Bubb, Vivien J.
Quinn, John P.
Koks, Sulev
author_sort Pfaff, Abigail L.
collection PubMed
description The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited knowledge of the specific loci from which this expression occurs in ALS. The long interspersed element-1 (L1) is the only autonomous retrotransposon in the human genome and members of this family of elements maintain the ability to mobilise. Despite L1s contributing to 17% of the human genome only 80–100 L1s encode the required proteins for mobilisation and are retrotransposition competent. Identifying the specific loci from which L1 expression occurs will inform on the potential functional consequences of their expression, such as the potential for somatic retrotransposition or DNA damage caused by the endonuclease activity of the ORF2 protein of the L1. Here we characterised L1 loci expression using the L1EM tool (https://github.com/FenyoLab/L1EM) in RNA sequencing data from 518 samples across four tissues (motor cortex, frontal cortex, cerebellum and cervical spinal cord) in the Target ALS cohort obtained from the New York Genome Center. There was a significant reduction in total intact L1 expression (those that encode functional proteins) in two brain regions of individuals with ALS compared to controls and clustering of the ALS brain regions occurred based on their intact L1 expression profile. Although overall the levels of L1 expression were reduced in ALS/ALS with other neurological disorder (ND) there were individuals in which L1s were expressed at much higher levels than the rest of the ALS/ALSND cohort. Expressed L1 loci were more frequently located in introns compared to those not expressed and the level of L1 expression positively correlated with the expression of the gene in which it was located. Significant differences were observed in the expression profiles of L1s in ALS and specific features of these elements, such as location in the genome and whether or not they are intact, were significantly associated with those that were expressed in the cohort. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00914-x.
format Online
Article
Text
id pubmed-8961898
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89618982022-03-30 Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis Pfaff, Abigail L. Bubb, Vivien J. Quinn, John P. Koks, Sulev Mol Brain Research The activation and dysregulation of retrotransposons has been identified in the CNS of individuals with the fatal neurodegenerative disorder Amyotrophic lateral sclerosis (ALS). This includes elements from multiple different families and subfamilies of retrotransposons, however there is limited knowledge of the specific loci from which this expression occurs in ALS. The long interspersed element-1 (L1) is the only autonomous retrotransposon in the human genome and members of this family of elements maintain the ability to mobilise. Despite L1s contributing to 17% of the human genome only 80–100 L1s encode the required proteins for mobilisation and are retrotransposition competent. Identifying the specific loci from which L1 expression occurs will inform on the potential functional consequences of their expression, such as the potential for somatic retrotransposition or DNA damage caused by the endonuclease activity of the ORF2 protein of the L1. Here we characterised L1 loci expression using the L1EM tool (https://github.com/FenyoLab/L1EM) in RNA sequencing data from 518 samples across four tissues (motor cortex, frontal cortex, cerebellum and cervical spinal cord) in the Target ALS cohort obtained from the New York Genome Center. There was a significant reduction in total intact L1 expression (those that encode functional proteins) in two brain regions of individuals with ALS compared to controls and clustering of the ALS brain regions occurred based on their intact L1 expression profile. Although overall the levels of L1 expression were reduced in ALS/ALS with other neurological disorder (ND) there were individuals in which L1s were expressed at much higher levels than the rest of the ALS/ALSND cohort. Expressed L1 loci were more frequently located in introns compared to those not expressed and the level of L1 expression positively correlated with the expression of the gene in which it was located. Significant differences were observed in the expression profiles of L1s in ALS and specific features of these elements, such as location in the genome and whether or not they are intact, were significantly associated with those that were expressed in the cohort. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00914-x. BioMed Central 2022-03-28 /pmc/articles/PMC8961898/ /pubmed/35346298 http://dx.doi.org/10.1186/s13041-022-00914-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pfaff, Abigail L.
Bubb, Vivien J.
Quinn, John P.
Koks, Sulev
Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title_full Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title_fullStr Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title_full_unstemmed Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title_short Locus specific reduction of L1 expression in the cortices of individuals with amyotrophic lateral sclerosis
title_sort locus specific reduction of l1 expression in the cortices of individuals with amyotrophic lateral sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961898/
https://www.ncbi.nlm.nih.gov/pubmed/35346298
http://dx.doi.org/10.1186/s13041-022-00914-x
work_keys_str_mv AT pfaffabigaill locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis
AT bubbvivienj locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis
AT quinnjohnp locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis
AT kokssulev locusspecificreductionofl1expressioninthecorticesofindividualswithamyotrophiclateralsclerosis